tuzi
Lv71
5000 积分
2022-09-20 加入
-
Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein
1个月前
已完结
-
Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin
1个月前
已完结
-
Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
7个月前
已完结
-
Ecological catalysis and phytoextraction: Symbiosis for future
9个月前
已完结
-
The effect of food on the relative bioavailability of rapidly dissolving immediate- release solid oral products containing highly soluble drugs
10个月前
已完结
-
Total tibio-tarsal section for tuberculosis
11个月前
已关闭
-
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
1年前
已完结
-
Avacincaptad Pegol: First Approval By: Kang, Connie Drugs (2023), 83(15), 1447-1453 | Language: English, Database: CAplus and MEDLINE
1年前
已完结
-
Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug Application for Resmetirom for the Treatment of NASH with Liver Fibrosis. Retrieved September 13, 2023 from
1年前
已完结
-
A pro-drug of semaglutide intended for once weekly treatment
1年前
已关闭